FDA NAGBABALA LABAN SA PAGGAMIT NG UV DEVICES BILANG PANG-DISINFECT KONTRA COVID-19

Ni Raiza F. Cabugwang
Photo courtesy of pia.gov.ph
Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

Sa inilabas na Advisory 2020-2052 ng Food and Drug Administration (FDA) kamakailan lamang, nagbabala ang ahensya sa masamang epekto sa kalusugan ng paggamit ng ultraviolet (UV) emitting devices bilang pang-disinfect para makaiwas sa COVID-19.

Sa kasalukuyan ay madalas na ginagamit ang mga ito sa mga commercial center at mga pampublikong lugar at sasakyan.

Ayon sa FDA, ang exposure sa UV radiation ay maaaring maging sanhi ng pangangati ng balat at magdulot ng pinsala sa mata.

“The International Commission on Non-Ionizing Radiation does not recommend the use of UV lamps for consumers or personal use,” ani FDA Director General Enrique Domingo.

Dagdag pa ni Dir. Gen. Domingo, ang exposure sa UV-A o soft UV ay maaaring humantong sa skin aging, samantalang ang contact naman sa UV-C o disinfection lamps ay pwedeng mauwi sa pagkasunog ng balat, skin cancer, o katarata.

“The FDA strongly advises against the use of UV light for COVID-19 disinfection near or on human body parts,” pahayag ni Domingo.

Sa ilalim ng FDA Act of 2009, inaatasan ang ahensya na mangasiwa sa pagkontrol ng paggamit ng radiation devices, tulad ng UV devices.

CONTACT US

Anchored on its mantra, “Sentro ng Katotohanan, Tapat sa Mamamayan”, Balita Central Digital complements and supports the Balita Central newspaper published bi-monthly to combat fake news and to provide the public with easy-to-digest news bits that are sourced solely from the Presidency and government agencies. 

Balita Central is under the supervision of the Bureau of Communications Services (BCS), one of the attached agencies of the Presidential Communications Operations Office (PCOO).

Launched on February 28, 2019 at the Manila Light Rail Transit System Line 2 (LRT-2) Cubao Station, Quezon City, it also aims to raise awareness among local communities about the policies, programs, and accomplishments of the Presidency. 

Through this platform, Balita Central Digital aims to reach further the online community to deliver more accurate information and communication services in order to educate the citizenry regarding national issues which would enlighten them to be engaged and be empowered in contributing to building a better nation.

Balita Central is situated at the BCS Headquarters located beside the Philippine Cancer Society along San Rafael, San Miguel, Malacañang Complex, Manila City. Its official website address is balitacentral.ph.

For inquiries and feedback, Balita Central may be contacted at editorialdesk.bcs@gmail.com.